141 related articles for article (PubMed ID: 16259963)
1. Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.
Meczes EL; Azim-Araghi A; Ottley CJ; Pearson DG; Tilby MJ
Biochem Pharmacol; 2005 Dec; 70(12):1717-25. PubMed ID: 16259963
[TBL] [Abstract][Full Text] [Related]
2. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
3. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
Tilby MJ; Johnson C; Knox RJ; Cordell J; Roberts JJ; Dean CJ
Cancer Res; 1991 Jan; 51(1):123-9. PubMed ID: 1703029
[TBL] [Abstract][Full Text] [Related]
4. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
5. Production of a high-affinity monoclonal antibody specific for 7-(benzo[alpha]pyren-6-yl) guanine and its application in a competitive enzyme-linked immunosorbent assay.
Casale GP; Rogan EG; Stack D; Devanesan P; Cavalieri EL
Chem Res Toxicol; 1996 Sep; 9(6):1037-43. PubMed ID: 8870993
[TBL] [Abstract][Full Text] [Related]
6. Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.
Fichtinger-Schepman AM; Dijt FJ; Bedford P; van Oosterom AT; Hill BT; Berends F
IARC Sci Publ; 1988; (89):321-8. PubMed ID: 3198216
[TBL] [Abstract][Full Text] [Related]
7. DNA adducts of cisplatin and carboplatin in tissues of cancer patients.
Poirier MC; Egorin MJ; Fichtinger-Schepman AM; Yuspa SH; Reed E
IARC Sci Publ; 1988; (89):313-20. PubMed ID: 3058599
[TBL] [Abstract][Full Text] [Related]
8. Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
Liedert B; Pluim D; Schellens J; Thomale J
Nucleic Acids Res; 2006 Mar; 34(6):e47. PubMed ID: 16571898
[TBL] [Abstract][Full Text] [Related]
9. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
[TBL] [Abstract][Full Text] [Related]
10. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies.
Iwamoto TA; Kobayashi N; Imoto K; Yamamoto A; Nakamura Y; Yamauchi Y; Okumura H; Tanaka A; Hanaoka F; Shibutani S; Miyagawa S; Mori T
DNA Repair (Amst); 2004 Nov; 3(11):1475-82. PubMed ID: 15380103
[TBL] [Abstract][Full Text] [Related]
11. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.
Beljanski V; Villanueva JM; Doetsch PW; Natile G; Marzilli LG
J Am Chem Soc; 2005 Nov; 127(45):15833-42. PubMed ID: 16277526
[TBL] [Abstract][Full Text] [Related]
12. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
Veal GJ; Dias C; Price L; Parry A; Errington J; Hale J; Pearson AD; Boddy AV; Newell DR; Tilby MJ
Clin Cancer Res; 2001 Aug; 7(8):2205-12. PubMed ID: 11489793
[TBL] [Abstract][Full Text] [Related]
13. LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.
Chválová K; Sari MA; Bombard S; Kozelka J
J Inorg Biochem; 2008 Feb; 102(2):242-50. PubMed ID: 17961652
[TBL] [Abstract][Full Text] [Related]
14. Quantitative profiling of in vivo generated cisplatin-DNA adducts using different isotope dilution strategies.
García Sar D; Montes-Bayón M; Blanco González E; Sierra LM; Aguado L; Comendador MA; Koellensperger G; Hann S; Sanz-Medel A
Anal Chem; 2009 Dec; 81(23):9553-60. PubMed ID: 19886652
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
Reed E; Gupta-Burt S; Litterst CL; Poirier MC
Carcinogenesis; 1990 Dec; 11(12):2117-21. PubMed ID: 1979937
[TBL] [Abstract][Full Text] [Related]
16. GA and AG sequences of DNA react with cisplatin at comparable rates.
Monjardet-Bas V; Bombard S; Chottard JC; Kozelka J
Chemistry; 2003 Oct; 9(19):4739-45. PubMed ID: 14566881
[TBL] [Abstract][Full Text] [Related]
17. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
[TBL] [Abstract][Full Text] [Related]
18. Development of a monoclonal antibody recognizing benzo[c]phenanthrenediol epoxide-DNA adducts: application to immunohistochemical detection of DNA damage.
Zhang YJ; Geacintov NE; Santella RM
Chem Res Toxicol; 1997 Sep; 10(9):948-52. PubMed ID: 9305575
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
Sundquist WI; Lippard SJ; Stollar BD
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
[TBL] [Abstract][Full Text] [Related]
20. Antibody recognition of melphalan adducts characterized using immobilized DNA: enhanced alkylation of G-Rich regions in cells compared to in vitro.
McCartney H; Martin AM; Middleton PG; Tilby MJ
Chem Res Toxicol; 2001 Jan; 14(1):71-81. PubMed ID: 11170510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
